Novavax Stock News

Here's a look at 3 biotech short squeeze candidates. For investors looking for short-term gains, technical analysis provides key insights on potential entry and exit points.

COVID-19 cases have been on the rise, and the CDC expects hospitalizations will increase. Novavax's updated vaccine has been effective against new variants and could offer protection.

Short selling is a risky strategy that involves betting against a stock's price, hoping that it will fall and generate profits for the trader. However, when a stock rises instead of falls, short selle

President Biden has requested additional funding for new coronavirus vaccines. He plans to encourage people in this country to receive these shots.

The COVID-19 virus is evolving in white-tailed deer at triple the rate it evolves in humans–and future changes could have serious consequences for people as well as livestock, according to a study p

There's no way to predict with 100% accuracy what stocks will face short squeezes or when they could happen. However, companies with high short interest and potential business tailwinds are prime cand

The updated Covid vaccines from Pfizer, Moderna and Novavax still need green lights from the FDA and the CDC before they roll out to the public.

In studies on small animals and primates, Novavax's (NVAX) updated monovalent COVID-19 vaccine generates a robust immune response against the currently dominating Eris variant.

Biotech company Novavax Inc (NYSE:NVAX) announced that its Covid vaccine is effective against the Eris variant.

The Nasdaq has taken a rather large hit in recent weeks, sinking about 7.5% between July 18 and Aug 17. Two of the main reasons for the decline are worries about U.S. inflation and the Chinese econom

Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing.

Novavax just announced promising news that could help lead to much-needed income later this year. The vaccine maker has expressed concerns about its ability to survive.

Shares of COVID-19 vaccine makers soared after reports suggest that the Biden administration will start a campaign urging citizens to vaccinate themselves with updated shots vaccine in the upcoming fa

Novavax's vaccine and new shots from Pfizer and Moderna are expected to roll out in the U.S. within weeks, pending potential approvals from the FDA.

Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the market performance of Covid vaccine stocks, as companies prepare to roll out new modified boosters to combat new varian